Co-administration of AAV Vectors with SVP-Rapamycin Enables Vector Re-administration in Pre-clinical Gene Therapy Study Published in Nature Communications by Généthon and Selecta Biosciences

World News: . []

EVRY France and WATERTOWN Mass Oct 05 2018 GLOBE NEWSWIRE) -- Gnthon a non-profit RD organization founded by the AFM-Tlthon and Selecta Biosciences Inc NasdaqSELB a clinical-stage biopharmaceutical company today announced that Na...

More news and information about Selecta Biosciences, Inc.; Généthon

Published By:

Globe Newswire: 15:01 GMT Friday 5th October 2018

Published: .

Search for other references to "administration" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us